In biomanufacturing, equipment retirement is rarely about mechanical failure. More often, it’s the loss of OEM support, the disappearance of a clear upgrade path, or outright product discontinuation following corporate acquisitions. A platform that once had reliable service and spare parts pipelines can suddenly be left without them—leaving process teams running critical bioreactors with control systems that are outdated, unsupported, and unable to integrate with today’s digital infrastructure.
Replacement vs. Retrofitting
The instinctive response is often to replace the entire system. But this approach overlooks the fact that many components remain viable. The vessel itself may be mechanically sound, pumps and mass flow controllers may still be in calibration, and load cells may be delivering accurate readings. Replacing these along with the controller amounts to scrapping assets with years of productive life left.
Retrofitting, an alternative too often overlooked, can reduce costs and downtime significantly. A smarter path begins with a technical audit of each subsystem to determine what can be retained and what must be upgraded. In most cases, the heart of the work lies in replacing the control architecture with a modern PLC/HMI platform, integrating existing peripherals, and enabling open-standard communications such as OPC UA or MQTT for seamless interoperability and future expansion.
The Financial and Operational Benefits of Retrofitting
The financial difference between replacement and retrofitting is dramatic. Replacing a stainless-steel or single-use bioreactor package can run anywhere from $700,000 to over $1 million per unit—including vessel, controller, pumps, MFCs, and scales. By contrast, a retrofit that preserves viable peripherals and focuses on the control layer typically costs only 15–30% of that amount—roughly $120,000–$240,000.
Even after accounting for commissioning, validation, and minor peripheral updates, capital savings of 50–85% are common. Retrofitting can also be completed in weeks—often aligned with scheduled maintenance—compared to the months of lead time, installation, and revalidation required for a full replacement. Reduced downtime and avoided lost production runs can equal or even exceed the direct capital savings.
A Smarter Path Forward
When viewed through an engineering and economic lens, the case for retrofitting is clear: evaluate each component on technical merit, retain what still meets specification, and replace only the elements that limit performance, compliance, or integration. This strategy extends the operational life of existing assets, focuses capital where it delivers the greatest return, and ensures adaptability in an industry where standards, tools, and vendor landscapes evolve rapidly.
At Wautoma Biotech, this approach reflects our broader focus on helping customers preserve their investments while enabling the future of bioprocessing. Retrofitting bioreactor platforms is one way we deliver cost-effective, future-proof technologies that align with evolving facility needs and regulatory demands.
Further reading on the costs for bioreactor system replacements:
- How Much Does a Bioreactor Cost? Excedr, https://www.excedr.com/blog/how-much-does-a-bioreactor-cost.
- How Much Does a Pilot-Scale Bioreactor Cost? Synapse by Patsnap, https://synapse.patsnap.com/article/how-much-does-a-pilot-scale-bioreactor-cost.
- Bioreactor Controller Rebuild Brings New Life to Old Reactor. ILS Automation, https://ils-automation.com/case-studies/bioreactor-controller-rebuild.